CDK8 and CDK19 have been implicated as key rheostats in cellular homeostasis and developmental programming

CDK8 and CDK19 are cyclin-dependent kinases that play important roles in regulating gene expression and cellular processes such as proliferation and differentiation. These kinases are part of the Mediator complex, which acts as a bridge between transcription factors and RNA polymerase II to regulate transcription.

Recent studies have highlighted the role of CDK8 and CDK19 in cellular homeostasis and developmental programming. These kinases have been shown to regulate the expression of genes involved in cell cycle progression, cell fate determination, and differentiation.

CDK8 and CDK19 have also been implicated in the development of various diseases, including cancer and neurological disorders. Dysregulation of these kinases can lead to aberrant gene expression and cellular processes, contributing to disease progression.

Targeting CDK8 and CDK19 is a promising strategy for the development of novel therapeutics for various diseases. Several inhibitors of these kinases are currently being developed and tested in clinical trials